Recent Discoveries of Diagnostic, Prognostic and Predictive Biomarkers for Pancreatic Cancer
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with a dismal prognosis that is frequently diagnosed at an advanced stage. Although less common than other malignant diseases, it currently ranks as the fourth most common cause of cancer-related death in the European Union with a five...
Main Authors: | Andrii Khomiak, Marius Brunner, Maximilian Kordes, Stina Lindblad, Rainer Christoph Miksch, Daniel Öhlund, Ivonne Regel |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/11/3234 |
Similar Items
-
Biomarkers for pancreatic cancer based on tissue and serum metabolomics analysis in a multicenter study
by: Rui Zhao, et al.
Published: (2023-02-01) -
Current Strategies and Future Perspectives for Precision Medicine in Pancreatic Cancer
by: Ivonne Regel, et al.
Published: (2020-04-01) -
The Microbiome in PDAC—Vantage Point for Future Therapies?
by: Nina Pfisterer, et al.
Published: (2022-12-01) -
Bile Acids and Microbiota Interplay in Pancreatic Cancer
by: Pratibha Malhotra, et al.
Published: (2023-07-01) -
Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics
by: Ariadna Martín-Blázquez, et al.
Published: (2020-04-01)